BackPelthos Therapeutics Overview

Pelthos Therapeutics Common Stock

Pelthos Therapeutics's common stock is $0.

Get informed when a big investor buys or sells

+ Follow
Common Stock
$0.00
↓ 100.00% YoYΔ $-621.00 vs prior year quarter

Peer average / median

Loading

Pelthos Therapeutics Common Stock History

Loading

Pelthos Therapeutics vs. peers: Common Stock Comparison

Loading

Pelthos Therapeutics Common Stock Growth (YoY per quarter)

Latest change versus the prior comparable period (same company). Positive growth indicates new issuance/dilution; negative growth indicates reductions/buybacks.

Loading

Pelthos Therapeutics (PTHS) FAQ

As of the most recent data (March 2026), PTHS shows a common stock of $0. That compares with $620 in the prior-year period — down 100.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PTHS's common stock is now $0 (was $620) — a 100.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Pelthos Therapeutics is outperforming or lagging.

Tracking PTHS's common stock over time shows whether Pelthos Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 That compares with $620 in the prior-year period — down 100.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Pelthos Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $0) with ownership activity and broader fundamentals.